Abstract
Beta-blocker therapy is critical in the management of coronary artery disease. Although its role is better defined in the management of acute myocardial infarction with areas of lingering controversy, β-blocker use in terms of cardiovascular outcomes in stable coronary artery disease is less understood. In this heterogenous population, important questions arise about what groups of patients benefit most from β-blockers and the appropriate duration of use.
Original language | English (US) |
---|---|
Title of host publication | Beta-Blockers |
Subtitle of host publication | Physiological, Pharmacological and Therapeutic Implications |
Publisher | Nova Science Publishers, Inc. |
Pages | 287-298 |
Number of pages | 12 |
ISBN (Electronic) | 9781536133127 |
ISBN (Print) | 9781536133110 |
State | Published - Jan 1 2018 |
ASJC Scopus subject areas
- Medicine(all)
- Pharmacology, Toxicology and Pharmaceutics(all)